Skip to main content

CORRECTION article

Front. Cardiovasc. Med., 04 April 2022
Sec. Cardiovascular Epidemiology and Prevention
Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.888829

Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study

This article is a correction to:

  1. The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study

    1. Read original article
\nSoo Jin Na,Soo Jin Na1,2Jong-Chan Youn &#x;Jong-Chan Youn3*†Hye Sun LeeHye Sun Lee4Soyoung JeonSoyoung Jeon4Hae-Young LeeHae-Young Lee5Hyun-Jai ChoHyun-Jai Cho5Jin-Oh ChoiJin-Oh Choi6Eun-Seok JeonEun-Seok Jeon6Sang Eun LeeSang Eun Lee7Min-Seok KimMin-Seok Kim7Jae-Joong KimJae-Joong Kim7Kyung-Kuk HwangKyung-Kuk Hwang8Myeong-Chan ChoMyeong-Chan Cho8Shung Chull ChaeShung Chull Chae9Seok-Min KangSeok-Min Kang10Dong-Ju ChoiDong-Ju Choi11Byung-Su YooByung-Su Yoo12Kye Hun KimKye Hun Kim13Byung-Hee OhByung-Hee Oh14Sang Hong Baek &#x;Sang Hong Baek3*†
  • 1Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
  • 2Department of Medicine, Catholic University Graduate School, Seoul, South Korea
  • 3Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul, South Korea
  • 4Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, South Korea
  • 5Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
  • 6Department of Internal Medicine, Sungkyunkwan University College of Medicine, Seoul, South Korea
  • 7Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
  • 8Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, South Korea
  • 9Department of Internal Medicine, Kyungpook National University College of Medicine, Daegu, South Korea
  • 10Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
  • 11Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea
  • 12Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea
  • 13Department of Cardiovascular Medicine, Chonnam National University Medical School, Gwangju, South Korea
  • 14Department of Internal Medicine, Mediplex Sejong Hospital, Incheon, South Korea

A Corrigendum on
The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study

by Na, S. J., Youn, J.-C., Lee, H. S., Jeon, S., Lee, H.-Y., Cho, H.-J., Choi, J.-O., Jeon, E.-S., Lee, S. E., Kim, M.-S., Kim, J.-J., Hwang, K.-K., Cho, M.-C., Chae, S. C., Kang, S.-M., Choi, D.-J., Yoo, B.-S., Kim, K. H., Oh, B.-H., and Baek, S. H. (2022). Front. Cardiovasc. Med. 9:791446. doi: 10.3389/fcvm.2022.791446

In the original article, there was an error. An author name was incorrectly spelled as “Kye Hoon Kim.” The correct spelling is “Kye Hun Kim.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: acute heart failure syndrome, spironolactone, mineralocorticoid receptor antagonists, drug therapy, outcome

Citation: Na SJ, Youn J-C, Lee HS, Jeon S, Lee H-Y, Cho H-J, Choi J-O, Jeon E-S, Lee SE, Kim M-S, Kim J-J, Hwang K-K, Cho M-C, Chae SC, Kang S-M, Choi D-J, Yoo B-S, Kim KH, Oh B-H and Baek SH (2022) Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study. Front. Cardiovasc. Med. 9:888829. doi: 10.3389/fcvm.2022.888829

Received: 03 March 2022; Accepted: 16 March 2022;
Published: 04 April 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Na, Youn, Lee, Jeon, Lee, Cho, Choi, Jeon, Lee, Kim, Kim, Hwang, Cho, Chae, Kang, Choi, Yoo, Kim, Oh and Baek. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jong-Chan Youn, am9uZy5jaGFuLnlvdW4mI3gwMDA0MDtnbWFpbC5jb20=; Sang Hong Baek, d2hpdGVzaCYjeDAwMDQwO2NhdGhvbGljLmFjLmty

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.